Your browser doesn't support javascript.
loading
In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma.
Philipp-Abbrederis, Kathrin; Herrmann, Ken; Knop, Stefan; Schottelius, Margret; Eiber, Matthias; Lückerath, Katharina; Pietschmann, Elke; Habringer, Stefan; Gerngroß, Carlos; Franke, Katharina; Rudelius, Martina; Schirbel, Andreas; Lapa, Constantin; Schwamborn, Kristina; Steidle, Sabine; Hartmann, Elena; Rosenwald, Andreas; Kropf, Saskia; Beer, Ambros J; Peschel, Christian; Einsele, Hermann; Buck, Andreas K; Schwaiger, Markus; Götze, Katharina; Wester, Hans-Jürgen; Keller, Ulrich.
Afiliación
  • Philipp-Abbrederis K; III. Medical Department of Hematology and Medical Oncology, Technische Universität München, Munich, Germany.
  • Herrmann K; Department of Nuclear Medicine, Universitätsklinikum Würzburg, Würzburg, Germany ulrich.keller@lrz.tum.de Herrmann_K1@ukw.de.
  • Knop S; Department of Internal Medicine II, Division of Hematology and Medical Oncology, Universitätsklinikum Würzburg, Würzburg, Germany.
  • Schottelius M; Pharmaceutical Radiochemistry, Technische Universität München, Munich, Germany.
  • Eiber M; Department of Nuclear Medicine, Technische Universität München, Munich, Germany.
  • Lückerath K; Department of Nuclear Medicine, Universitätsklinikum Würzburg, Würzburg, Germany.
  • Pietschmann E; III. Medical Department of Hematology and Medical Oncology, Technische Universität München, Munich, Germany.
  • Habringer S; III. Medical Department of Hematology and Medical Oncology, Technische Universität München, Munich, Germany German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Gerngroß C; Department of Nuclear Medicine, Technische Universität München, Munich, Germany.
  • Franke K; III. Medical Department of Hematology and Medical Oncology, Technische Universität München, Munich, Germany.
  • Rudelius M; Institute of Pathology, Universitätsklinikum Würzburg and CCC Mainfranken, Würzburg, Germany.
  • Schirbel A; Department of Nuclear Medicine, Universitätsklinikum Würzburg, Würzburg, Germany.
  • Lapa C; Department of Nuclear Medicine, Universitätsklinikum Würzburg, Würzburg, Germany.
  • Schwamborn K; Institute of Pathology, Technischen Universität München, Munich, Germany.
  • Steidle S; III. Medical Department of Hematology and Medical Oncology, Technische Universität München, Munich, Germany.
  • Hartmann E; Institute of Pathology, Universitätsklinikum Würzburg and CCC Mainfranken, Würzburg, Germany.
  • Rosenwald A; Institute of Pathology, Universitätsklinikum Würzburg and CCC Mainfranken, Würzburg, Germany.
  • Kropf S; Scintomics GmbH, Fürstenfeldbruck, Germany.
  • Beer AJ; Department of Nuclear Medicine, Technische Universität München, Munich, Germany.
  • Peschel C; III. Medical Department of Hematology and Medical Oncology, Technische Universität München, Munich, Germany German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Einsele H; Department of Internal Medicine II, Division of Hematology and Medical Oncology, Universitätsklinikum Würzburg, Würzburg, Germany.
  • Buck AK; Department of Nuclear Medicine, Universitätsklinikum Würzburg, Würzburg, Germany.
  • Schwaiger M; Department of Nuclear Medicine, Technische Universität München, Munich, Germany German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Götze K; III. Medical Department of Hematology and Medical Oncology, Technische Universität München, Munich, Germany German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Wester HJ; Pharmaceutical Radiochemistry, Technische Universität München, Munich, Germany German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany Scintomics GmbH, Fürstenfeldbruck, Germany.
  • Keller U; III. Medical Department of Hematology and Medical Oncology, Technische Universität München, Munich, Germany German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany ulrich.keller@lrz.tum.de Herrmann_K1@ukw.de.
EMBO Mol Med ; 7(4): 477-87, 2015 Apr.
Article en En | MEDLINE | ID: mdl-25736399
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sondas Moleculares / Regulación Neoplásica de la Expresión Génica / Receptores CXCR4 / Tomografía de Emisión de Positrones / Imagen Molecular / Mieloma Múltiple / Proteínas de Neoplasias Límite: Animals / Humans Idioma: En Revista: EMBO Mol Med Asunto de la revista: BIOLOGIA MOLECULAR Año: 2015 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sondas Moleculares / Regulación Neoplásica de la Expresión Génica / Receptores CXCR4 / Tomografía de Emisión de Positrones / Imagen Molecular / Mieloma Múltiple / Proteínas de Neoplasias Límite: Animals / Humans Idioma: En Revista: EMBO Mol Med Asunto de la revista: BIOLOGIA MOLECULAR Año: 2015 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido